CorMedix Inc (CRMD) USD0.001
Sell:$9.99Buy:$10.40
$0.59
(5.38%)
- This stock can be held in a
Stocks and Shares ISA$0.59
(5.38%)$0.59
(5.38%)Company Information
About this company
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 mg/mL, and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). In addition to DefenCath, the Company has sponsored a pre-clinical research collaboration for the use of taurolidine as a possible treatment for rare pediatric tumors.
Key people
Key facts
- EPICCRMD
- LocationUnited States
- SectorHealthcare
- IndustryBiotechnology & Drugs
- ISINUS21900C3088
- Market cap$629.83m
- Employees82
- Shares in issue60.68m
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.